Gulden debutes the Rowe OCT Model Eye

Article

Gulden Ophthalmics recently introduced Rowe OCT Model Eye, a solid-state tissue phantom that is used by clamping it to an instrument and initiating an OCT test.

Elkins Park, PA-Gulden Ophthalmics recently introduced Rowe OCT Model Eye, a solid-state tissue phantom that is used by clamping it to an instrument and initiating an OCT test. It eliminates the need to use staff members or patients to check, practice, and use OCT equipment. Because it produces a standard test result based on a normal macula it provides a stabile, long-term benchmark for OCT instruments.

Imaging a choroidal nevus

According to the company, OCT Model Eye can be used for system demonstrations and tests; staff education, instruction, and practice; OCT instrument research and development; and as a standard for multi-instrument DME trials at several sites.            

The OCT Model Eye features a realistic, six-layer retina 300 um thick, 4.8 mm in diameter; a 120 um deep foveal pit; photoreceptor inner segment (IS)/outer segment (OS)/retinal pigment epithelium (RPE) layer with choroidal transition. It is fluid free and easy to image with a large 12.6 mm cornea and 8 mm diameter pupil and is 23.5 mm in axial length.  Images using the OCT Model Eye exhibit clear layer structure, foveal pit, and IS/OS/RPE layer.

The OCT Model Eye is provided and stored in a wooden case with instructions, an attachment rod for mounting on an ophthalmic instrument chin rest, and a mounting clamp.

Laser injury requires second opinion

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Dr. Julie Rodman previews her SECO presentations
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
© 2025 MJH Life Sciences

All rights reserved.